AN2 Therapeutics, Inc. Common Stock — Institutional Ownership

Which tracked institutions hold ANTX, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.

16
Funds holding
$15588808
Total value held
Buying
14 added/new · 2 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $8060991 1665494 +1346726 +422.48%
2 Ameriprise Financial Inc $2599390 537064 +537064 NEW BUY
3 State Street Corp $1508154 311602 +196400 +170.48%
4 Northern Trust Corp $1040217 214921 +171725 +397.55%
5 Bank Of America Corp /De/ $705686 145803 -247899 -62.97%
6 Goldman Sachs Group Inc $425596 87933 +87933 NEW BUY
7 Ubs Group Ag $358576 74086 +74086 NEW BUY
8 Bank Of New York Mellon Corp $327552 67676 +67676 NEW BUY
9 Morgan Stanley $238995 49379 -184808 -78.91%
10 Wells Fargo & Company/Mn $108363 22389 +22389 NEW BUY
11 Invesco Ltd. $66981 13839 +13839 NEW BUY
12 Citigroup Inc $59373 12267 +12267 NEW BUY
13 Jpmorgan Chase & Co $55184 10971 +10971 NEW BUY
14 Barclays Plc $26577 5491 +5091 +1272.75%
15 Royal Bank Of Canada $5000 938 +938 NEW BUY
16 Federated Hermes, Inc. $2173 449 +449 NEW BUY

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.